Solid lipid nanoparticles for ocular drug delivery

@article{Seyfoddin2010SolidLN,
  title={Solid lipid nanoparticles for ocular drug delivery},
  author={Ali Seyfoddin and John P. Shaw and Raida S Al-Kassas},
  journal={Drug Delivery},
  year={2010},
  volume={17},
  pages={467 - 489}
}
Ocular drug delivery remains challenging because of the complex nature and structure of the eye. Conventional systems, such as eye drops and ointments, are inefficient, whereas systemic administration requires high doses resulting in significant toxicity. There is a need to develop novel drug delivery carriers capable of increasing ocular bioavailability and decreasing both local and systemic cytotoxicity. Nanotechnology is expected to revolutionize ocular drug delivery. Many nano-structured… Expand
Lipid-based nanocarriers for ocular drug delivery
Abstract Ocular drug delivery remains challenging because of the complex nature and structure of the eye. Conventional systems, such as eye drops and ointments, are inefficient, whereas systemicExpand
Designing lipid nanoparticles for topical ocular drug delivery.
TLDR
The main limitations of topical ocular drug delivery are discussed and how correctly designed lipid nanoparticles can be highly valuable tools to overcome the constraints imposed by the ocular surface are described. Expand
Application of lipid nanoparticles to ocular drug delivery
TLDR
This review highlights the main ocular barriers to drug delivery, as well as the most common eye diseases suitable for pharmacological treatment in which lipid nanoparticles have proved efficacious as alternative delivery systems. Expand
Lipid nanoparticles as drug/gene delivery systems to the retina.
TLDR
Scientific results are summarized that evidence the potential application of lipid nanoparticles as drug delivery systems for the retina and also as nonviral vectors in gene therapy of retina disorders, although much more effort is still needed before these lipidic systems could be available in the market. Expand
Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery
TLDR
This review tried to focus on current research in ocular delivery of drug substances giving special emphasis to liposomal delivery system as they have the ability to entrap both hydrophobic and hydrophilic drugs and are suitable for delivery to both the anterior and posterior segment of the eye. Expand
Nanocrystal for ocular drug delivery: hope or hype
TLDR
The success achieved in conquering various challenges of ocular delivery by the use of nanocrystals is highlighted while emphasizing on its advantages and application for ocular formulation. Expand
Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.
TLDR
Nanoemulsions are abridged with concepts to design clinically advantageous ocular drug delivery to spike the interest of those contemplating a foray in this field. Expand
Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part II ‐ Ocular drug‐loaded lipid nanoparticles
TLDR
The latest findings, potential applications, and challenges related to the use of lipid nanoparticles for ocular drug delivery are comprehensively discussed. Expand
Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery
TLDR
The development of organic and inorganic nanoparticles for ophthalmic applications is summarized and the potential nanoformulations in clinical trials as well as the products that have become a commercial reality are highlighted. Expand
Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor
TLDR
The SLN formulations demonstrated improved performance of entrapped CXB while mitigating the key parameters of ocular inflammation in rabbits and have exhibited prolonged retention over ocular surfaces as evident from results of gamma scintigraphy using 99mTc labeled SLNs. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 120 REFERENCES
Nanocarriers in ocular drug delivery: an update review.
TLDR
This review presents an overview of the various aspects of the ocular drug delivery, with special emphasis on nanocarrier based strategies, including structure of eye, its barriers, delivery routes and the challenges/limitations associated with development of novelnanocarriers. Expand
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
TLDR
DNPs have been shown to be amenable to targeting of the drug to the site of action, leading to a decreases in the dose required and a decrease in side effects, which makes them a novel polymeric drug delivery device, which fulfils the requirements for ophthalmic application. Expand
Microspheres and nanoparticles used in ocular delivery systems
TLDR
Microparticles and nanoparticles are colloidal drug carriers in the micro- and submicron range developed to overcome solubility problems of poorly soluble drugs as well as for long acting injectable depot formulations and specific drug targeting options. Expand
Liposome ocular delivery systems
TLDR
A historical account of the studies is presented and a complete understanding of the liposome interaction with ocular tissues should enable the design of liposomal products suitable for ocular drug delivery. Expand
Nanotechnology in ocular drug delivery.
TLDR
An insight into the various constraints associated with ocular drug delivery is provided, recent findings and applications of various nanoparticulate systems like microemulsions, nanosuspensions, nanoparticles, liposomes, niosomes, dendrimers and cyclodextrins are summarized and how the various upcoming of nanotechnology can be utilized to explore the frontiers of ocularDrug delivery and therapy are depicted. Expand
Colloidal carriers for ophthalmic drug delivery.
TLDR
This review will discuss recent progress and specific development issues relating to colloidal drug delivery systems, such as liposomes, niosomes, nanoparticles, and microemulsions in ocular drug delivery, and the benefits of using colloidal carriers in intravitreal injections for posterior drug delivery. Expand
Ophthalmic drug delivery systems—Recent advances
TLDR
Polymeric gels, colloidal systems, cyclodextrins and collagen shields have been developed as a new continuous-delivery system for drugs that provide high and sustained levels of drugs to the cornea, despite a problem of tolerance. Expand
Nanomedicines for ocular NSAIDs: safety on drug delivery.
TLDR
This review focuses on microemulsions, polymeric nanoparticles, liposomes, solid lipid nanop articles, and drug nanocrystals as novel high efficiency delivery systems of anti-inflammatory drugs in ophthalmic applications. Expand
Vesicular systems in ocular drug delivery: an overview.
TLDR
The constraints with conventional ocular therapy are reviewed and various novel approaches, in general, to improve ocular bioavailability of the drugs, advantages of vesicular approach over these and the future challenges to render the vesicle system more effective are explored. Expand
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement.
TLDR
Results indicated that NLC was a biocompatible and potential nanocarrier for ocular drug delivery enhancement and could improve the ocular retention and penetration of ocular therapeutics. Expand
...
1
2
3
4
5
...